Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The material and technical base of fluorographic units of primary health care facilities and its development promises].

Vestnik rentgenologii i radiologii·2012
Same author

[The First Russian Research Institute of Phthisiopulmonology is 90 years old].

Tuberkulez i bolezni legkikh·2010
Same author

[Assessment of the training of phthisiatricians in the regions of Russia].

Problemy tuberkuleza i boleznei legkikh·2009
Same author

[The specific features of therapy for allergic rhinitis in children].

Vestnik otorinolaringologii·2009
Same author

[Legal aspects of compulsory hospitalization of incompliant patients with tuberculosis].

Problemy tuberkuleza i boleznei legkikh·2009
Same author

[A social backing program and motivation provision in patients with tuberculosis].

Problemy tuberkuleza i boleznei legkikh·2009

Related Experiment Video

Updated: Jul 5, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

[A procedure for calculating needs for antituberculous drugs].

E M Bogorodskaia, N V Antonova, M I Perel'man

    Problemy Tuberkuleza I Boleznei Legkikh
    |May 3, 2008
    PubMed
    Summary

    A new unified electronic form (UEF) was developed to accurately calculate needs for antituberculous drugs (ATD). This method improves drug management and ensures efficient treatment for tuberculosis patients.

    Related Experiment Videos

    Last Updated: Jul 5, 2026

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
    23:06

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

    Published on: August 11, 2008

    Area of Science:

    • Public Health
    • Pharmacoeconomics
    • Infectious Disease Management

    Background:

    • Accurate quantification of antituberculous drug (ATD) requirements is crucial for effective tuberculosis control programs.
    • Existing methods for calculating ATD needs may not fully account for diverse treatment regimens and patient populations.
    • Ensuring adequate drug supply while minimizing waste requires a standardized and reliable calculation procedure.

    Purpose of the Study:

    • To develop and validate a standardized procedure for calculating the needs for antituberculous drugs (ATD) within the Russian Federation.
    • To create a computer-based tool that facilitates accurate and efficient ATD needs assessment.
    • To improve the management and allocation of ATD resources for tuberculosis treatment and prevention.

    Main Methods:

    • Development of a unified electronic form (UEF) utilizing invariable formulas and coefficients for computer-based ATD needs calculation.
    • Estimation of ATD needs based on average drug requirements per patient per course, considering standard chemotherapy regimens, chemoprophylaxis, and other treatment scenarios.
    • Integration of data from existing reporting documents (TB Form No. 2, Form No. 030-4/y, Form No. 33) into the UEF for comprehensive needs assessment.
    • Validation of the UEF procedure across 82 subjects of the Russian Federation.

    Main Results:

    • The majority of patients receiving ATDs were undergoing chemoprophylaxis, with only 18.3% receiving treatment for active tuberculosis.
    • Analysis revealed potential underreporting of chronic tuberculous processes and treatment regimens, particularly those involving second-line agents.
    • The UEF procedure highlighted discrepancies between reported data and actual patient treatment, emphasizing the need for improved personified registration and standardized data collection.
    • Implementation of the UEF demonstrated the necessity for a standardized approach to ATD needs calculation across different healthcare facilities.

    Conclusions:

    • The developed unified electronic form (UEF) provides a standardized and reliable method for calculating antituberculous drug (ATD) needs.
    • Improved personified registration of patients, especially those with multidrug-resistant tuberculosis, is essential for accurate second-line ATD requirement calculations.
    • Enhancements to existing TB reporting forms are recommended to capture comprehensive patient data, including chemoprophylaxis and specialized treatment courses.
    • A responsible approach to ATD consumption, accurate indication determination, and diligent UEF completion are vital for efficient drug resource management.